Last Updated : August 1, 2019
Details
FilesProject Status:
Completed
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA1056-000
Question
- What is the clinical effectiveness of nivolumab, pembrolizumab, or ipilimumab-nivolumab in patients with melanoma who progressed after adjuvant therapy with nivolumab or pembrolizumab?
- What is the clinical effectiveness of atezolizumab, nivolumab or pembrolizumab in patients with recurrent/metastatic non-small cell lung cancer (NSCLC) who progressed after consolidation therapy with durvalumab?
- What are the evidence-based guidelines on the timing of retreatment with immune checkpoint inhibitors?
Files
Last Updated : August 1, 2019